Matches in Wikidata for { <http://www.wikidata.org/entity/Q66079326> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q66079326 description "clinical trial" @default.
- Q66079326 description "ensayu clínicu" @default.
- Q66079326 description "klinisch onderzoek" @default.
- Q66079326 description "клінічне випробування" @default.
- Q66079326 name "Study of MK-7684 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors (MK-7684-001)" @default.
- Q66079326 name "Study of MK-7684 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors" @default.
- Q66079326 type Item @default.
- Q66079326 label "Study of MK-7684 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors (MK-7684-001)" @default.
- Q66079326 label "Study of MK-7684 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors" @default.
- Q66079326 prefLabel "Study of MK-7684 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors (MK-7684-001)" @default.
- Q66079326 prefLabel "Study of MK-7684 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors" @default.
- Q66079326 P1132 Q66079326-7B455644-8C1E-402E-BB07-B2974B115B52 @default.
- Q66079326 P1476 Q66079326-CBA26A25-AA95-47CB-AFFE-DDC46F0758C5 @default.
- Q66079326 P17 Q66079326-5E376BB8-BDDD-4D82-BD77-8D6F7AC885AD @default.
- Q66079326 P17 Q66079326-6FEFC4B0-574A-48BF-921B-2C9B7259C2DA @default.
- Q66079326 P17 Q66079326-8EE61C71-A95E-4534-A618-DE966D866EFF @default.
- Q66079326 P17 Q66079326-C6456C74-5F1A-4756-A742-E53967015664 @default.
- Q66079326 P2899 Q66079326-E0A78439-89C1-431C-8369-383F03BCC47F @default.
- Q66079326 P3098 Q66079326-8391C522-5194-4235-A17E-B92910F05F86 @default.
- Q66079326 P31 Q66079326-ED59DB26-48AC-4F96-B4BA-A295605B72D5 @default.
- Q66079326 P4844 Q66079326-7217A2F7-E801-455B-9477-F01E55CDA302 @default.
- Q66079326 P4844 Q66079326-B45ACAF7-4DFA-44F3-B0A4-DB534028823C @default.
- Q66079326 P4844 Q66079326-D9E1B344-3069-43C4-BCF8-840E9508B218 @default.
- Q66079326 P580 Q66079326-770895FF-7E44-40D8-B76F-B2EBA09F4541 @default.
- Q66079326 P582 Q66079326-FD149479-8F62-4F93-869B-21A6A55D1278 @default.
- Q66079326 P6099 Q66079326-CFF955BE-362C-4E50-83C5-B3C440BBDAFA @default.
- Q66079326 P6153 Q66079326-8E1B04E0-3B00-43C8-A39D-505BC2AB289E @default.
- Q66079326 P8363 Q66079326-6AFF85D2-CEA9-428B-AF47-710CB91C798A @default.
- Q66079326 P1132 "+392" @default.
- Q66079326 P1476 "A Phase 1 Trial of MK-7684 as Monotherapy and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors" @default.
- Q66079326 P17 Q17 @default.
- Q66079326 P17 Q30 @default.
- Q66079326 P17 Q408 @default.
- Q66079326 P17 Q801 @default.
- Q66079326 P2899 "+18" @default.
- Q66079326 P3098 "NCT02964013" @default.
- Q66079326 P31 Q30612 @default.
- Q66079326 P4844 Q13896859 @default.
- Q66079326 P4844 Q415220 @default.
- Q66079326 P4844 Q415588 @default.
- Q66079326 P580 "2016-12-13T00:00:00Z" @default.
- Q66079326 P582 "2022-06-03T00:00:00Z" @default.
- Q66079326 P6099 Q5452194 @default.
- Q66079326 P6153 Q58218611 @default.
- Q66079326 P8363 Q78089383 @default.